News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,984 Results
Type
Article (43344)
Company Profile (353)
Press Release (670287)
Section
Business (211558)
Career Advice (2079)
Deals (36340)
Drug Delivery (90)
Drug Development (82047)
Employer Resources (172)
FDA (16640)
Job Trends (15269)
News (355499)
Policy (33312)
Tag
Academia (2683)
Alliances (52107)
Alzheimer's disease (1251)
Approvals (16569)
Artificial intelligence (150)
Bankruptcy (357)
Best Places to Work (11828)
Biotechnology (252)
Breast cancer (122)
Cancer (1100)
Cardiovascular disease (98)
Career advice (1739)
Cell therapy (246)
Clinical research (65022)
Collaboration (404)
Compensation (199)
COVID-19 (2615)
C-suite (100)
Data (1135)
Diabetes (153)
Diagnostics (6405)
Earnings (86419)
Employer resources (151)
Events (114114)
Executive appointments (320)
FDA (17187)
Funding (365)
Gene therapy (187)
GLP-1 (593)
Government (4427)
Healthcare (19384)
Infectious disease (2702)
Inflammatory bowel disease (109)
Interviews (319)
IPO (16638)
Job creations (3813)
Job search strategy (1488)
Layoffs (425)
Legal (8072)
Lung cancer (173)
Manufacturing (180)
Medical device (13901)
Medtech (13906)
Mergers & acquisitions (19781)
Metabolic disorders (409)
Neuroscience (1531)
NextGen Class of 2024 (6831)
Non-profit (4601)
Northern California (1495)
Obesity (233)
Opinion (190)
Patents (108)
People (58475)
Phase I (20347)
Phase II (28620)
Phase III (21253)
Pipeline (457)
Postmarket research (2572)
Preclinical (8746)
Radiopharmaceuticals (254)
Rare diseases (224)
Real estate (6216)
Regulatory (22091)
Research institute (2448)
Resumes & cover letters (360)
Southern California (1320)
Startups (3827)
United States (13820)
Vaccines (578)
Weight loss (172)
Date
Today (138)
Last 7 days (781)
Last 30 days (3846)
Last 365 days (36669)
2024 (33625)
2023 (41134)
2022 (52397)
2021 (56996)
2020 (55616)
2019 (48410)
2018 (36442)
2017 (33541)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (754)
Arizona (201)
Asia (39769)
Australia (6607)
California (3387)
Canada (1296)
China (253)
Colorado (150)
Connecticut (158)
Europe (86858)
Florida (462)
Georgia (124)
Illinois (361)
Indiana (202)
Kansas (99)
Maryland (588)
Massachusetts (2685)
Michigan (173)
Minnesota (280)
New Jersey (972)
New York (967)
North Carolina (743)
Northern California (1495)
Ohio (141)
Pennsylvania (853)
South America (1149)
Southern California (1320)
Texas (472)
Utah (94)
Washington State (372)
713,984 Results for "bioaffinity technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
October 30, 2024
·
4 min read
Press Releases
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
November 14, 2024
·
11 min read
Press Releases
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
November 4, 2024
·
5 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease, reported 139% growth in the number of pulmonology practices and physicians offering CyPath® Lung to patients since Jan. 1, 2024.
June 12, 2024
·
6 min read
Business
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, reported financial results for the three months ended March 31, 2024.
May 15, 2024
·
10 min read
Press Releases
bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
October 10, 2024
·
4 min read
Lone Star Bio
bioAffinity Technologies In The News - January 30, 2024
bioAffinity Technologies, Inc. provides a summary of recent Company news.
January 30, 2024
·
5 min read
Business
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
bioAffinity Technologies, Inc. today reported financial results for the three and 12 months ended December 31, 2023.
April 1, 2024
·
11 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
bioAffinity Technologies, Inc. reported accelerating growth of 375% in CyPath® Lung tests ordered and processed over the past three months as compared to the previous three months.
March 5, 2024
·
5 min read
Lone Star Bio
bioAffinity Technologies In the News
Here is a summary of the latest news about bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer and lung disease.
January 8, 2024
·
5 min read
1 of 71,399
Next
